Wealth Alliance Advisory Group, LLC Vbi Vaccines Inc Transaction History

Wealth Alliance Advisory Group, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 02, 2023	SELL	$0.29 - $0.64 $12,687 - $27,999	-43,749 Reduced 28.36%	110,502 $33,000
Q4 2022 Jan 17, 2023	SELL	$0.38 - $22.5 $14,724 - $871,852	-38,749 Reduced 20.08%	154,251 $0
Q3 2022 Oct 12, 2022	BUY	$0.73 - $23.4 $132,130 - $4.24 Million	181,000 Added 1508.33%	193,000 $136,000
Q4 2021 Jan 13, 2022	BUY	$2.21 - $3.22 $26,520 - $38,640	12,000 New	12,000 $28,000

688K

Ticker VBIV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 258,256,992
Market Cap $5.17M
Description
VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines for the treatment of infectious diseases and immuno-oncology. The company offers Sci-B-Vac, a prophylactic hepatitis B (HBV) vaccine. It also engages in the development of VBI-2601 (BRII-179), an immunotherapeutic candidate for the treatment of chronic HBV infection. The...

Get notified when there are updates to the investment portfolio of Wealth Alliance Advisory Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Wealth Alliance Advisory Group, LLC with notifications on news.